Big news! A groundbreaking eye therapy developed by MERI trainee Celia Bisbach and MERI Director David Gamm has been nominated for a 2025 WARF Innovation Award!
Designed to treat retinal diseases, this new approach targets and eliminates VEGF—the protein responsible for abnormal blood vessel growth—right at the site of disease. The result?
✨ Fewer injections
✨ Protection of healthy tissue
✨ Potentially better outcomes for people with macular degeneration and other serious vision conditions
This could be a major leap forward in preserving sight. Learn more about this WARF innovation below.